Thursday November 15, 2018 09:22

Heathcare Press Release : 07 Apr 2017

Four Ways to Eat Yourself into Good Health Heathcare—07 Apr 17

You are what you eat. This proverb is present for many of us throughout our lives — serving as both friend, and foe. Ultimately, the lesson is that food forms a large part of our overall health, helping balance our bodies, giving us energy,

Successful Financial Year 2016 for Boehringer Ingelheim Heathcare—07 Apr 17

INGELHEIM, Germany--7 Apr--PRNewswire/InfoQuest

The research-driven pharmaceutical company Boehringer Ingelheim can look back on a successful financial year. Net sales increased in all businesses. At the same time, Boehringer Ingelheim completed the transformation of the company as planned in 2016, and will in future focus on human pharmaceuticals, animal health and biopharmaceutical contract manufacturing. "Both our human pharmaceuticals as well as our animal health medications contributed to our positive business performance with good growth rates," explained Hubertus von Baumbach, Chairman of the Board of Managing Directors, at the annual press conference today. "We look to the future with confidence -- especially after successfully completing the transformation of our business."

In 2016, Boehringer Ingelheim generated net sales of around 15.9 billion euros, representing an increase of 7.3 per cent in currency-adjusted terms (+7.1 per cent in euro terms). Since operating income improved by 27 per cent to around 2.9 billion euros, the return on net sales came to 18.1 per cent. Boehringer Ingelheim i

Occlutech Obtains European CE Mark for its Novel PmVSD Occluder Heathcare—07 Apr 17

Occlutech, a leading innovator of implants to treat structural heart disease, today announced that it has obtained European CE Mark approval for its Perimembranous Ventricular Septal Defect (PmVSD) Occluder. The device is a specifically designed implant